Mechanisms of cell death in neurodegenerative disorders

Journal of Neural Transmission, Supplement

Volumn , Issue 59, 2000, Pages 95-114

  Jellinger, K A ^a   Stadelmann, C ^b,c  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CASPASE 3; DNA FRAGMENT; TAU PROTEIN; CASP3 PROTEIN, HUMAN; CASPASE;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; BRAIN STEM; CELL DEATH; CELL GRANULE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEWY BODY; MICROGLIA; MORPHOLOGY; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; NICK END LABELING; OLIGODENDROGLIA; PARKINSON DISEASE; PONS ANGLE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTO ONCOGENE; SHY DRAGER SYNDROME; TEGMENTUM; APOPTOSIS; BRAIN; ENZYME ACTIVATION; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AMYLOID; APOPTOSIS; BRAIN; CASPASE 3; CASPASES; CELL DEATH; DNA FRAGMENTATION; ENZYME ACTIVATION; HUMANS; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; NEURONS;

EID: 0033624411     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6781-6_13     Document Type: Article

References (123)

1. Adamec E, Vonsattel JP, Nixon RA (1999) DNA strand breaks in Alzheimer's disease. Brain Res 849: 67-77
2. Anderson AJ, Su JH, Cotman CW (1996) DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area and effect of post mortem delay. J Neurosci 16: 1710-1719
3. Anglade P, Vyas S, Javoy-Agid F, Herrero M-T, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Agid Y (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 12: 25-31
4. Arendt T, Holzer M, Fruth R, Brückner MK, Gärtner U (1998) Phosphorylation of tau, Aβ-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiol Aging 19: 3-13
5. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 8: 711-715
6. Banati RB, Daniel SE, Path MRC, Blunt SB (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov Disord 13: 221-227
7. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche O, Seitelberger F, Grundke-Iqbal I, Wisniewski HM (1989) Accumulation of abnormally phosphorylated T precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 477: 90-99
8. Bergeron C, Davis A, Lang AE (1998) Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol 8: 355-365
9. Boonman Z, Isacson O (1999) Apoptosis in neuronal development and transplantation: role of caspases and trophic factors. Exp Neurol 156: 1-18
10. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
11. Braak E, Braak H, Mandelkow E-M (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neurophil threads. Acta Neuropathol 87: 554-567
12. Bredesen DE (1995) Neural apoptosis. Ann Neurol 38: 839-851
13. Burke RE, Kholodilov NG (1998) Programmed cell death: does it play a role in Parkinson's disease? Ann Neurol 44 [Suppl 1]: S126-S133
14. Butterworth NJ, Williams L, Bullock JY, Love DR, Faull RLM, Dragunow M (1998) Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's-disease striatum. Neuroscience 87: 49-53
15. Campbell BCV, McLean CA, Culvenor JG, Gai WP et al (2000) Solubility of alphasynuclein differs between multiple system atrophy and dementia with Lewy bodies. J Neurochem (in press)
16. Chambers CB, Lee JM, Troncoso JC, Reich S, Muma NA (1999) Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease. Ann Neurol 46: 325-332
17. Charles PD, Robertson D, Kerr LD, Lonce S, Austin MT, Gelbman BD, Whetsell WO, Davis TL (1997) Evidence of apoptotic cell death in multiple-system atrophy. Ann Neurol 42: 408-409
18. Clarke PGH (1990) Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol 181: 195-213
19. Clarke PGH (1999) Apoptosis versus necrosis. In: Koliatsosue M, Ratan RR (eds), Cell death and disease of the nervous system, Humana Press, Totowa NY, pp 3-28
20. Cotman CW (1998) Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease. Neurobiol Aging 19 [Suppl 1]: S29-S32
21. Cotman CW, Su JH (1996) Mechanisms of neuronal cell death in Alzheimer's disease. Brain Pathol 6: 493-506
22. Cotman CW, Ivins KH, Anderson AJ (1999) Apoptosis in Alzheimer disease. In: Terry RD, Katzman R, Black KJ, Sisodia SS (eds), Alzheimer disease, 2nd edn, Lippincott, Williamns & Wilkins, Philadelphia, pp. 347-357
23. de la Monte SM, Sohn YK, Wands JR (1997) Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci 152: 73-83
24. de la Monte SM, Sohn YK, Ganju N, Wands JR (1998) p53- and CD95-associated apoptosis in neurodegenerative diseases. Lab Invest 78: 401-411
25. Dragunow M, Faull R, Lawlor P, Beilharz EJ, Singleton K, Walker EB, Mee E (1995) In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 6: 1053-1057
26. Duan W, Zhang Z, Gash DM, Mattson MP (1999) Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease. Ann Neurol 46: 587-597
27. Galvin JE, Lippa CF (1999) Apoptosis in familial Alzheimer's disease (abstr.). Ann Neurol 46: 452
28. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, LeBlanc A, Smith D, Rigby M, Shearman MS, Clarke EE, Zheng H, Van Der Ploeg LH, Ruffolo SC, Thornberry NA, Xanthoudakis S, Zamboni RJ, Roy S, Nicholson DW (1999) Involvement of caspases in proteolytic cleavage of Alzheimer's amyloidbeta precursor protein and amyloidogenic A beta peptide formation. Cell 97: 395-406
29. Giannakopoulos P, Kövari E, Savioz A, De Bilabao F, Dubois-Dauphin M, Hof PR, Bouras C (1999) Differential distribution of presenilin-1, Bax, and Bc1-X in Alzheimer's disease and frontotemporal dementia. Acta Neuropathol 98: 141-149
30. Gleckman AM, Jiang Z, Liu Y, Smith TW (1999) DNA fragmentation in neurons and glial cells indicates cellular injury but not apoptosis in Pick's disease. Acta Neuropathol 98: 55-61
31. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka K, Lassmann H (1994) Differentiation between cellular apoptosis and necrosis by combined use of in situ tailing and nick translation techniques. Lab Invest 71: 219-225
32. Graeber MB, Grasbon-Frodl E, Abell-Aleff P, Kösel S (1999) Nigral neurons are likely to die of a mechanism other than classical apoptosis in Parkinson' s disease. Parkinsonism Relat Disord 5: 187-192
33. Grohshal N, Smiley JF, DeMaggio AJ, Hoekstra MF et al (1999) A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease. Am J Pathol 155: 1163-1172
34. Gschwind M, Huber G (1995) Apoptotic cell death induced by β-amyloid 1-42 peptide is cell type dependent. J Neurochem 65: 292-300
35. Guo Q, Sopher BL, Furukawa K, Pham DG, Robinson N, Martin GM, Mattson MP (1997) Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J Neurosci 17: 4212-4222
36. Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW, Bondada V, Rangnekar VM, Mattson MP (1998) Par-4 is a mediator of neuronal degeneration associated with the patho-genesis of Alzheimer disease. Nature Med 4: 957-962
37. Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP (1999a) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nature Med 5: 101-106
38. Guo Q, Sebastian L, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP (1999b) Increased vunerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid β-peptide toxicity: central roles of Superoxide production and caspase activation. J Neurochem 72: 1019-1029
39. Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S et al (2000) Caspase-3. A vulner-ability factor and final effector in apopotitc death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 97: 2875-2880
40. Hauw J-J, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44: 2015-2019
41. Hockenbery D (1995) Defining apoptosis. Am J Pathol 146: 16-19
42. Ivins KJ, Thornton PL, Rohn TT, Cotman CW (1999) Neuronal apoptosis induced by β-amyloid is mediated by caspase-8. Neurobiol Dis 6: 440-449
43. Jellinger KA (1999a) Mechanisms of cell death in Parkinson's disease and related disorders. Neurosci News 2: 27-35
44. Jellinger KA (1999b) Is there apoptosis in Lewy body disease? Acta Neuropathol 97: 413-415
45. Jellinger KA (2000) Cell death mechanisms in Parkinson's disease. J Neural Transm 107: 1-29
46. Jeon BS, Kholodilov NG, Oo TF, Kim SY, Tomaselli KJ, Srinivasan A, Stefanis L, Burke RE (1999) Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra. J Neurochem 73: 322-333
47. Kaltschmidt B, Uherek M, Wellmann H, Volk B, Kaltschmidt C (1999) Inhibition of NF-κB potentiates amyloid β-mediated neuronal apoptosis. Proc Natl Acad Sci USA 96: 9409-9414
48. Keller JN, Guo Q, Holtsberg FW, Bruce-Keller AJ, Mattson MP (1998) Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J Neurosci 18: 4439-4450
49. Kihira T, Yoshida S, Hironishi M, Wakayama I, Yase Y (1998) Neuronal degeneration in amyotrophic lateral sclerosis is TI mediated by a possible mechanism different from classical apoptosis. Neuropathology 18: 301-308
50. Kingsbury AE, Fester OJF, Nisbet AP, et al (1995) Tissue pH as an indicator of mRNA preservation in post-mortem brain. Mol Brain Res 28: 311-318
51. Kingsbury AE, Marsden CD, Foster OJF (1998) DNA fragmentation in human substantia nigra: apoptosis or perimortem effect? Mov Disord 13: 877-884
52. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Perry G, Whitehouse PJ, Taniguchi T (1998) Alteration of proteins regulating apoptosis, Bc1-2, Bc1-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res 780: 260-269
53. Kösel S, Egensperger R, v. Eitzen U, Mehraein P, Graeber M (1997) On the question of apootosis in the Parkinsonian substantia nigra. Acta Neuropathol 93: 105-108
54. Kwok JBJ, Li Q-X, Hallupp M, Whyte S et al (2000) Novel Leu723Pro amyloid precursor protein mutation increases amyloid β42(43) peptide levels and induces apoptosis. Ann Neurol 47: 249-253
55. Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46: 598-605
56. Lantos PL (1999) The definition of multiple system atrophy: A review of recent developments. J Neuropathol Exp Neurol 57: 1099-1111
57. Lassman H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM (1995) Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 89: 35-41
58. Li YP, Bushnell AF, Lee CM, Perlmutter LS, Wong SK (1996) β-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res 738: 196-204
59. Lu DC, Rabizadeh S, Chandra S, Shayya RF, Ellerby LM, Ye X, Salvesen GS, Koo EH, Bredesen DF (2000) A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor. Nat Med 6: 397-404
60. Lucassen PJ, Chung WCJ, Kamphorst W, Swaab DF (1997) DNA damage distribution in the human brain as shown by in situ end labelling. Area-specific differences in aging and Alzheimer's disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol 887-900
61. MacGibbon GA, Lawlor PA, Walton M, Sirimanne E, Faull RLM, Synek B, Mee E, Connor B, Dragunow M (1997) Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease. Exp Neurol 147: 316-332
62. Marcus DL, Thomas CG, Levin R, Golomb J, Recht P, Freedman ML (1996) Evidence for apoptosis in Alzheimer's disease. J Invest Med 44: 308A
63. Marcus DL, Strafaci JA, Miller DC, Masia S, Thomas CG, Rosman J, Hussain S, Freedman ML (1998) Quantitative neuronal c-Fos and c-Jun expression in Alzheimer's disease. Neurobiol Aging 19: 393-400
64. Marshall KA, Daniel SE, Cairns N, Jenner P, Halliwell B (1997) Upregulation of the antiapoptotic protein Bc1-2 may be early event in neurodegeneration: studies on Parkinson's incidental Lewy body disease. Biochem Biophys Res Commun 240: 84-87
65. Martin LJ (1999) Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J Neuropathol Exp Neurol 58: 459-471
66. Masliah E, Mallory M, Alford M, Tanaka S, Hansen LA (1998) Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease. J Neuropathol Exp Neurol 57: 1041-1052
67. Mattson MP, Partin J, Begley JG (1998) Amyloid β-peptide induces apoptosis-related events in synapses and dendrites. Brain Res 807: 167-176
68. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Loverstone S, Collerton D, Jansen ENH, de Vos RAI, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology 47: 1113-1124
69. McShea A, Harris PLR, Webster KR, Wahl AF, Smith MA (1997) Abnormal expression of the cell cycle regulators P 16 and CDK4 in Alzheimer's disease. Am J Pathol 50: 1933-1939
70. Michel PP, Lambeng N, Ruberg M (1999) Neuropharmacologic aspects of apoptosis: Significance for neurodegenerative diseases. Clin Neuropharmacol 22: 137-150
71. Micheli A, Atzori C, Pival R, Tortarolo M, Girelli M, Schiffer D, Bendotti C (1999) Lack of apoptosis in mice with ALS. Nat Med 5: 966-967
72. Milligan CE (2000) Caspase cleavage of APP results in a cytotoxic proteolytic peptide. Nat Med 6: 385-386
73. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 41: 479-486
74. Mochizuki H, Mori H, Mizuno Y (1997) Apoptosis in neurodegenerative disorders. J Neural Transm [Suppl 50]: 125-140
75. Mogi M, Togari A, Kondo T, Mizono Y et al (2000) Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brains. J Neural Transm 107: 335-341
76. Morsch R, Simon W, Coleman PD (1999) Neurons may live for decades with neurofibrillary tangles. J Neuropathol Appl Neurol 58: 188-197
77. Morrison BM, Hof PR, Morrison JH (1998) Determinants of neuronal vulnerability in neurodegenerative diseases. Ann Neurol 44 [Suppl 1]: S32-S44
78. Nagy ZS, Esiri MM (1997) Apoptosis-related protein expression in the hippocampus of Alzheimer's disease. Neurobiol Aging 18: 655-671
79. Nagy Z, Esiri MM, Smith AD (1997) Expression of cell division markers in the hippocampus of Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol 93: 294-300
80. Nishimura T, Akiyama H, Yonehara S, Kondo H, Ikeda K, Kato M, Iseki E, Kosaka K (1995) Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res 695: 137-145
81. Ohyagi Y, Yamada T, Asahara H, Taniwaki T, Nakabeppu Y, Younkin S, Kira J (1999) Amyloid-β protein 42 forms a 24-kd complex in normal cells and is deposited in apoptotic neurons (abstr). Ann Neurol 46: 453
82. Ohyagi Y, Yamada T, Nishioka K, Clarke NJ et al (2000) Selective increase in cellular Aβ42 is related to apoptosis but not necrosis. Neuroreport 11: 167-171
83. Olanow CW, Jenner P, Tatton N, Tatton WG (1998) Neurodegeneration in Parkinson's disease. In: Jankovic J, Tolosa E (eds) Parkinson's disease and movement disorders, 3rd edn. Williams & Wilkins, Baltimore, pp 67-103
84. Overmyer M, Kraszpulski M, Seppo H, Soininen H, Alafuzoff I (2000) DNA-fragmentation, gliosis and histological hallmarks of Alzheimer's disease. Acta Neurpathol 100 (in press)
85. Passer BJ, Pellegrini L, Vito P, Ganjei JK, D'Adamio L (1999) Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bc1-X-L - A potential role in modulating the threshold of cell death. J Biol Chem 274: 2400-2414
86. Patel T, Gores GJ, Kaufmann SH (1996) The role of proteases during apoptosis. FASEB J 10: 587-597
87. Perry G, Numomura A, Smith MA (1998a) A suicide note from Alzheimer disease neurons? Nat Med 4: 897-898
88. Perry G, Numomura A, Lucassen PJ, Lassmann H, Smith MA (1998b) Apoptosis and Alzheimer's disease. Science 282: 1265
89. Pettman B, Henderson CE (1998) Neuronal cell death. Neuron 20: 633-647
90. Probst-Cousin S, Rickert CH, Schmid KW, Gullotta F (1998) Cell mechanisms in multiple system atrophy. J Neuropathol Exp Neurol 57: 814-821
91. Robertson GS, Crocker SJ, Nicholson DW, Schulz JB (2000) Neuroprotection by the inhibition of apoptosis. Brain Pathol 10: 283-292
92. Selznick LA, Holtzman DM, Han BH, Gokder M, Srinivasan AN, Johnson MJ, Roth KA (1999) In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J Neuropathol Exp Neurol 58: 1020-1026
93. Selznick LA, Zheng TS, Flavell RA, Rakic P, Roth KA (2000) Amyloid beta-induced neuronal death is Bax-dependent but Caspase-independent. J Neuropathol Exp Neurol 59: 271-279
94. Sheng JG, Mrak RE, Griffin WST (1998) Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer's disease. J Neuropathol Exp Neurol 57: 323-328
95. Smale JG, Nichols NR, Brady DR, Finch CE, Horton WE Jr (1995) Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133: 225-230
96. Srinivasan A, Roth KA, Sayers RO, Shindler KS, Wong AM, Fritz LC, Tomaselli K (1998) In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ 5: 1004-1016
97. Stadelmann C, Brück W, Bancher C, Jellinger K, Lassmann H (1998) Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability but not apoptosis. J Neuropathol Exp Neurol 57: 456-464
98. Stadelmann C, Deckwerth TL, Scrinivasan A, Bancher C, Brück W, Jellinger K, Lassmann H (1999) Activation of caspase-3 in single apopototic neurons and granules of granulovacuolar degeneration in Alzheimer disease and Down's syndrome: a role for autophagy as antiapoptotic counterregulatory mechanism? Am J Pathol (submitted)
99. Su JH, Satou T, Anderson AJ, Cotman CW (1996) Up-regulation of Bc1-2 is associated with neuronal DNA damage in Alzheimer's disease. Neuroreport 7: 437-440
100. Su JH, Deng GM, Cotman CW (1997) Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bc1-2 expression, and brain pathology. J Neuropathol Exp Neurol 56: 86-93
101. Tan Z, Sun N, Schreiber SS (1998) Immunohistochemical localization of redox factor-1 (Ref-1) in Alzheimer's hippocampus. NeuroReport 9: 2749-2752
102. Tatton WG, Chalmers-Redman RME, Rideout HJ, Tatton NA (1999) Mitochondrial permeability in neuronal death: possible relevance to the pathogenesis of Parkinson's disease. Parkinsonism Relat Disord 5: 221-229
103. Thomas LB, Gates DJ, Richfield EK, O'Brien TF, Schweitzer JB, Steindler DA (1995) DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol 133: 265-272
104. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312-1316
105. Tompkins MM, Hill WD (1997) Contribution of somal Lewy bodies to neuronal death. Brain Res 775: 24-29
106. Tompkins MM, Basgall EJ, Zamrini E, Hill WD (1997) Apoptotic-like changes in Lewy body-associated disorders and normal aging in substantia nigral neurons. Am J Pathol 150: 119-131
107. Torp R, Su JH, Deng G, Cotman CW (1998) GADD45 is induced in Alzheimer's disease, and protects against apoptosis in vitro. Neurobiol Dis 5: 245-252
108. Tortosa A, Blanco R, Ferrer I (1998a) Bc1-2 and Bax protein expression in neurofibrillary tangles in progressive supranuclear palsy. NeuroReport 9: 1049-1052
109. Tortosa A, López W, Ferrer I (1998b) Bc1-2 and Bax protein expression in Alzheimer's disease. Acta Neuropathol 95: 407-412
110. Trojanowski JQ, Goedert M, Iwatsubo T, Lee VMY (1998) Fatal attractions - abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body-dementia. Cell Death Differ 5: 832-837
111. Troncoso JC, Sukhov RR, Kawas CH, Koliatsos VE (1996) In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease. Correlations with senile plaques and disease progression. J Neuropathol Exp Neurol 55: 1134-1142
112. Troost D, Aten J, Morsink F, de Jong JMBV (1995) Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons: Bc1-2 expression is increased in unaffected post-central gyrus. Neuropathol Appl Neurobiol 21: 498-504
113. Tu P-H, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, Nakajo S, Iwatsubo T, Trojanowski JQ, Lee VM-Y (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 44: 415-422
114. Vito P, Ghayur T, D'Adamio L (1997) Generation of antiapoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase-3 cleavage. J Biol Chem 272: 28315-28320
115. Vyas S, Javoy-Agid F, Herrero MT, Strada O, Boissiere F, Hibner U, Agid Y (1997) Expression of Bc1 2 in adult human brain regions with special reference to neurodegenerative disorders. J Neurochem 69: 223-231
116. Wang KKW (2000) Calpain and caspase; can you tell the difference? Trends Neurol Sci 23: 20-26
117. Wilson CA, Roms RW, Lee M-Y (1999) Intracellular APP processing and Aβ production in Alzheimer disease. J Neuropathol Exp Neurol 58: 787-794
118. Wolozin B, Iwasaki K, Vito P, et al (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274: 1710
119. Wüllner U, Kornhuber J, Weller M, Schulz JB, Löschmann PA, Riederer P (1999) Cell death and apoptosis regulating proteins in Parkinson's disease - a cautionary note. Acta Neuropathol 97: 408-412
120. Wyllie AH, Kerr JFR, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-305
121. Yamatsuji T, Matsui T, Okamoto T, Komatsuzaki K, Takeda S, Fukumoto H, Iwatsubo T, Suzuki N, Asami-Odaka A, Ireland S, Kinane B, Giambarella U, Nishimoto I (1996) G-protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science 272: 1349-1352
122. Yo YH, Fortini ME (1999) Apopototic activities of wild-type and Alzheimer's disease related mutant presenilins in Drosopihla melanogaster. J Cell Biol 146: 1351-1364
123. Zhang ZH, Hartmann H, Do VM (1998) Destabilization of β-catenin by mutations in presenilin-I potentiates neuronal apoptosis. Nature 395: 698-702